Conferences

Catalog

Abstracts

Calendar

6th Binaytara Precision Oncology Summit: At The Forefront of Targeted Cancer Therapy

Name: 6th Binaytara Precision Oncology Summit: At The Forefront of Targeted Cancer Therapy
Start: 2026-09-11T07:00:00+00:00
End: 2026-09-12T07:00:00+00:00
Location: Hyatt Regency San Francisco Downtown SOMA

Accreditation: 10.00 AMA PRA Category 1 Credit™ | 10.00 ABIM MOC II | 10.00 Nursing Contact Hours | 10.00 ACPE Pharmacy

Venue: Hyatt Regency San Francisco Downtown SOMA, 50 3rd Street, San Francisco, CA, United States

Start Date: September 11End Date: September 12, 2026

Overview

Trusted by Thousands of Attendees
Across Our Events

14+

Email if you have questions[email protected]

Our Speakers

Planning Committee

Mark Daniel Pegram, MD

Conference Co-Chair

Binaytara

James M. Ford, MD

Conference Co-Chair

Binaytara

Milana v Dolezal, MD

Abstract Committee

Binaytara

William Shomali, MD

Abstract Committee

Binaytara

Faculty

Milana v Dolezal, MD

Associate Chair

Binaytara

Sachdev P Thomas, MD

Associate Chair

Binaytara

Varun Monga, MD, MBBS

Associate Chair

Binaytara

James M. Ford, MD

Session Chair

Binaytara

Vivek Subbiah, MD

Session Chair

Binaytara

Andreas Varkaris, MD, PhD

Session Chair

Binaytara

Dennis Slamon, MD, PhD

Key Note Presenter

Binaytara

Siddhartha Yadav, MD

Topic Presenter

Binaytara

Melinda L. Telli, MD

Topic Presenter

Binaytara

Naoto Ueno, MD, PhD, FACP

Topic Presenter

Binaytara

Judith A. Varner, PhD

Topic Presenter

Binaytara

Byron Aram, MD

Topic Presenter

Binaytara

Andrei Iagaru, MD

Topic Presenter

Binaytara

Our Agenda

Day 1: Friday, September 11th, 2026

All timings are in Pacific Time (PDT, GMT-07:00) time.

09:00 AM - 10:00 AMRegistration, Breakfast, & Exhibits

10:00 AM - 10:30 AMKey Note Address

10:00 AM - 10:30 AM

Target Discovery and Validation – Dennis Slamon, MD, PhD

10:30 AM - 11:45 AM Germline Alterations in Human Cancers

10:30 AM - 10:45 AM

Overview of germline vs. somatic mutations in cancer predisposition - Role in therapy selection across tumor types – Siddhartha Yadav, MD

10:45 AM - 11:00 AM

Current targeted therapies for germline alterations – Melinda L. Telli, MD

11:00 AM - 11:15 AM

Near-Future Pipeline Agents Targeting Germline DNA alterations in Cancer Medicine

11:15 AM - 11:30 AM

VHL-targeted: Belzutifan for RCC/Pheo

11:30 AM - 11:45 AM

Panel Discussion

11:45 AM - 01:00 PMMolecular Diagnostics in Precision Oncology

11:45 AM - 12:00 PM

NHS-Galleri Trial

12:00 PM - 12:15 PM

Sensitive Detection of MRD in Early-stage Cancer – Milana v Dolezal, MD

12:15 PM - 12:30 PM

Controversies in Treatment-emergent Drug Resistance Mutations: Intervention Prior to RECIST Disease Progression

12:30 PM - 01:00 PM

Panel Discussion

01:00 PM - 02:00 PMLunch & Exhibits

02:00 PM - 03:00 PMAntibody-based Therapeutics

02:00 PM - 02:15 PM

Novel ADC Linker/Payload Considerations

02:15 PM - 02:30 PM

Therapeutic strategies targeting brain metastases

02:30 PM - 03:00 PM

Panel Discussion

03:00 PM - 03:20 PMBreak & Exhibits

03:20 PM - 04:20 PMMolecular Tumor Board 1: Interesting and Challenging Cases in Precision Oncology

Session Chair: James M. Ford, MD

04:20 PM - 05:35 PMDrug Resistance in Precision Oncology

Session Chair: Vivek Subbiah, MD

04:20 PM - 04:35 PM

Adaptive Feedback and Bypass Pathways

04:35 PM - 04:50 PM

Mechanisms of ADC Resistance – Naoto Ueno, MD, PhD, FACP

04:50 PM - 05:05 PM

Tumor Microenvironment Role – Judith A. Varner, PhD

05:05 PM - 05:35 PM

Panel Discussion

05:35 PM - 05:35 PMAdjourn Day 1

Day 2: Saturday, September 12th, 2026

07:00 AM - 08:00 AMRegistration, Breakfast & Exhibits

08:00 AM - 08:30 AMBinaytara's Efforts in Improving Cancer Care Disparities

About 6th Binaytara Precision Oncology Summit: At The Forefront of Targeted Cancer Therapy

Overview

Faculty and committee

Our Speakers

Conference program and agenda

Our Agenda

Venue and map

Accreditations and continuing education

Registration and pricing

Exhibitors and sponsorship

Our Speakers

Our Agenda